Exploring SI-BONE, Inc. (SIBN) Investor Profile: Who’s Buying and Why?

Ever wondered who's investing in SI-BONE, Inc. (SIBN) and what's driving their decisions? With a market capitalization of approximately $380.25 million as of April 2025, and a revenue of $37.5 million in the first quarter of 2024, SI-BONE is capturing attention. Are institutional investors leading the charge, or is it the insiders who are making the big moves? Considering the recent surge in total revenue, marking a 24.1% increase compared to the first quarter of 2023, understanding the investor landscape becomes crucial. Dive in to uncover the dynamics of SI-BONE's investor profile and the factors influencing their investment strategies.

SI-BONE, Inc. (SIBN) Who Invests in SI-BONE, Inc. (SIBN) and Why?

Understanding the investor profile of SI-BONE, Inc. (SIBN) provides valuable insights into the market's perception of the company and its future prospects. Examining the composition of investors—ranging from retail individuals to large institutional entities—helps to decipher the driving forces behind investment decisions and the overall sentiment surrounding SI-BONE, Inc. (SIBN).

Key Investor Types

The investor base of SI-BONE, Inc. (SIBN) is composed of a mix of retail and institutional investors. Each type brings different investment philosophies and strategies to the table.

• Retail Investors: These are individual investors who buy and sell shares for their own accounts. Their investment decisions are often influenced by factors such as personal financial goals, risk tolerance, and information gathered from various sources, including financial news, company reports, and advice from financial advisors.
• Institutional Investors: These are entities that pool money to purchase securities, real property, and other investment assets. They include:
  • Mutual Funds: These funds pool money from many investors to purchase a diversified portfolio of stocks, bonds, or other assets.
  • Hedge Funds: These funds use more aggressive investment strategies, such as leverage and short-selling, to generate higher returns.
  • Pension Funds: These funds manage retirement savings for employees and often invest in a mix of stocks, bonds, and other assets to generate long-term returns.
  • Insurance Companies: These companies invest premiums collected from policyholders to fund future claims and generate profits.
  • Endowments: These are funds donated to non-profit organizations, such as universities and hospitals, which are invested to generate income for the organization.

Institutional investors typically hold a significant portion of SI-BONE, Inc. (SIBN)'s shares due to the scale of their investments and their focus on long-term growth. Data regarding specific holdings and percentages can fluctuate, and consulting the latest financial reports and filings is essential for the most up-to-date information.

Investment Motivations

Investors are attracted to SI-BONE, Inc. (SIBN) for various reasons, largely centered around the company's growth prospects, market position, and potential for innovation in its specific market.

• Growth Prospects: Investors often look at SI-BONE, Inc. (SIBN)'s potential for revenue and earnings growth. This includes factors such as the company's ability to expand into new markets, develop new products, and increase sales in existing markets.
• Market Position: A strong market position can be a significant draw for investors. This includes factors such as market share, brand recognition, and competitive advantages.

Investment Strategies

The investment strategies employed by SI-BONE, Inc. (SIBN) investors can vary widely depending on their investment goals, risk tolerance, and time horizon.

• Long-Term Holding: Some investors adopt a long-term holding strategy, purchasing shares with the intention of holding them for several years or even decades. These investors are typically focused on the company's long-term growth potential and are willing to ride out short-term market fluctuations.
• Short-Term Trading: Other investors engage in short-term trading, buying and selling shares with the goal of profiting from short-term price movements. These investors may use technical analysis and other tools to identify trading opportunities.
• Value Investing: Value investors seek out companies that they believe are undervalued by the market. They look for companies with strong fundamentals, such as solid earnings, a strong balance sheet, and a capable management team, but whose shares are trading at a discount to their intrinsic value.

Understanding these diverse investment strategies provides a more nuanced view of the dynamics influencing SI-BONE, Inc. (SIBN)'s stock performance and investor relations.

To gain more insights into the company's financial standing, consider exploring: Breaking Down SI-BONE, Inc. (SIBN) Financial Health: Key Insights for Investors

SI-BONE, Inc. (SIBN) Institutional Ownership and Major Shareholders of SI-BONE, Inc. (SIBN)

Institutional ownership in SI-BONE, Inc. (SIBN) is significant, with 335 institutional owners and shareholders filing 13D/G or 13F forms with the Securities and Exchange Commission (SEC), holding a total of 51,920,552 shares.

As of April 16, 2025, the share price was $13.33, while it was $15.23 on April 17, 2024, representing a 12.48% decrease over the year.

Here is a list of the top institutional holders:

• BlackRock Inc.: Holds 3.83 million shares, representing 9.03% of the outstanding shares, with a value of $53,105,402 as of December 31, 2024.
• Brown Advisory Inc.: Holds 3.64 million shares, representing 8.58% of the outstanding shares, with a value of $50,420,164 as of December 31, 2024.
• Orbimed Advisors LLC: Holds 3.44 million shares, representing 8.11% of the outstanding shares, with a value of $47,683,515 as of December 31, 2024.
• Champlain Investment Partners, LLC: Holds 2.72 million shares.
• Vanguard Group Inc
• American Century Companies Inc
• ANONX - Small Cap Growth Fund I Class
• Silvercrest Asset Management Group Llc
• Granahan Investment Management Inc/ma
• Paradigm Capital Management Inc/ny

Other significant shareholders include insiders such as Skyline Venture Partners V LP, owning 11,059,955 shares (26.05%) valued at $148.98 million, and John Gordon Freund, owning 10,980,368 shares (25.86%) valued at $147.91 million.

Institutional investors play a crucial role in SI-BONE, Inc.'s stock price and strategy. Their investment decisions can significantly impact the company's market capitalization, which was $587.98 million as of April 17, 2025. However, it's worth noting that SI-BONE Inc’s market capitalization decreased from $850.12M in January to $587.98M in December 2024, a change of -30.84%.

Changes in institutional ownership can provide insights into the sentiment surrounding SI-BONE's stock. For instance, Morgan Stanley reported a 12.16% decrease in ownership of SIBN. Monitoring these changes can help investors understand the evolving dynamics of institutional interest in the company.

SI-BONE achieved adjusted EBITDA profitability in Q4 2024. The company’s worldwide revenue for the full year 2024 was between $167.0-$167.1 million, representing 20% growth year-over-year. The company ended Q4 2024 with approximately $150 million in cash and marketable securities.

Interested in learning more? Explore the Mission Statement, Vision, & Core Values of SI-BONE, Inc. (SIBN).

SI-BONE, Inc. (SIBN) Key Investors and Their Impact on SI-BONE, Inc. (SIBN)

Understanding the investor profile of SI-BONE, Inc. (SIBN) provides crucial insights into the company’s stability, growth potential, and strategic direction. Examining who is investing in SI-BONE, Inc. (SIBN) and their recent activities can reveal a lot about market sentiment and future expectations.

Institutional ownership is a significant factor in SI-BONE, Inc. (SIBN)’s stock performance. As of Q4 2023, institutional investors owned 77.60% of the company's stock. A detailed breakdown reveals the top institutional holders:

• Vanguard Group Inc: Holds 3,788,599 shares, representing 11.61% ownership.
• BlackRock Fund Advisors: Holds 2,944,348 shares, representing 9.02% ownership.
• State Street Global Advisors: Holds 1,661,776 shares, representing 5.09% ownership.
• Dimensional Fund Advisors LP: Holds 1,499,962 shares, representing 4.60% ownership.
• Geode Capital Management LLC: Holds 868,780 shares, representing 2.66% ownership.

These major institutional holders often influence the stock's stability and trading volume. Their decisions to increase or decrease their positions can significantly impact SI-BONE, Inc. (SIBN)’s stock price.

Recent moves by institutional investors indicate ongoing interest and adjustments in their stakes. For example, there have been notable increases and decreases in holdings:

• Millennium Management LLC: Increased its stake by 24.8% in Q4 2023, now holding 148,388 shares valued at $3.4 million.
• Victory Capital Management Inc.: Boosted its holdings by 12.2% in Q3 2023, owning 132,608 shares worth $2.424 million.
• Allspring Global Investments Holdings LLC: Increased its position by 4.5% in Q3 2023, holding 61,604 shares valued at $1.127 million.
• BlackRock Inc.: Increased its stake by 2.4% in Q3 2023, owning 2,944,348 shares valued at $53.834 million.
• Vanguard Group Inc.: Increased its stake by 1.4% in Q3 2023, owning 3,788,599 shares valued at $69.211 million.

Conversely, some institutions have reduced their positions:

• Granite Bay Wealth Management LLC: Decreased its stake by 75.0% in Q4 2023, selling 6,000 shares.
• Citadel Advisors LLC: Sold 4,378 shares in Q4 2023, reducing its holdings.

These transactions reflect different strategies and outlooks on SI-BONE, Inc. (SIBN)’s future performance. Monitoring these moves can provide valuable insights into the evolving investor confidence in the company.

Hedge funds also play a role in SI-BONE, Inc. (SIBN)’s investor landscape. While their holdings may be smaller compared to institutional giants, their trading activity can contribute to price volatility and market sentiment.

Here is a summary of ownership data:

Insider ownership, though smaller, is another crucial aspect. Significant insider holdings can indicate that the management’s interests are aligned with those of the shareholders, potentially signaling confidence in the company’s prospects.

For more insights into SI-BONE, Inc. (SIBN), you might find this resource helpful: SI-BONE, Inc. (SIBN): History, Ownership, Mission, How It Works & Makes Money.

SI-BONE, Inc. (SIBN) Market Impact and Investor Sentiment

Understanding investor sentiment and market reactions to SI-BONE, Inc. (SIBN) is crucial for gauging the company's current standing and future prospects. Recent trading activities, major shareholder positions, and analyst ratings provide a comprehensive view of market confidence and potential volatility.

As of February 8, 2024, SI-BONE's stock showed a notable performance with a Relative Strength Rating of 86. While this indicates strong momentum, it's essential to consider broader market trends and company-specific developments for a complete picture. Keep in mind that these ratings can fluctuate, reflecting changing investor perceptions and market conditions.

Institutional holdings often play a significant role in shaping a company's stock performance. Examining the behavior of major shareholders can offer insights into long-term confidence and potential strategic shifts. Notable institutional investors include:

• Vanguard Group Inc: Reported holding 2,399,988 shares.
• BlackRock Inc.: Reported holding 2,169,898 shares.
• RA Capital Management, L.P.: Reported holding 1,741,679 shares.
• Adage Capital Management L.P.: Reported holding 1,148,718 shares.
• State Street Corp: Reported holding 854,514 shares.

These large institutional positions can influence stock stability and trading volumes. Changes in their holdings are closely watched by other investors as potential signals of future performance.

Analyst ratings provide another layer of insight, reflecting expert evaluations of SI-BONE's prospects. For instance, as of December 12, 2024, analysts have issued the following recommendations:

These ratings, gathered from various sources, represent a consensus view on whether the stock is expected to outperform, underperform, or maintain pace with the market. A preponderance of 'buy' ratings suggests strong confidence in the company's potential, while 'hold' ratings indicate a more neutral outlook.

Monitoring these factors—investor sentiment, recent market reactions, and analyst perspectives—is essential for anyone looking to understand the dynamics of SI-BONE, Inc. (SIBN) and make informed investment decisions.

For further insights into SI-BONE, Inc. (SIBN) financial health, consider exploring: Breaking Down SI-BONE, Inc. (SIBN) Financial Health: Key Insights for Investors